Main Topics | Delta Cure - 4th International Meeting | Hannover,...
On this page you will find the Main Topics of the 4th Delta Cure...
On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments. On this page you will find the Main Topics of the 4th Delta Cure Meeting: HDV Epidemiology, Virology and Pathogenesis, Diagnosis, Staging and Disease progression, Current and new antiviral treatments.
Main Topics
HDV Epidemiology
- Africa
- Asia
- South America
- Immingrant populations in Western Countries
- Cascade of Care
Virology and Pathogenesis
- Virology: the latest insights
- Pathogenesis: insights from liver biopsies
- Are immune responses important in HDV infection?
- New HBV biomarkers: any role in HDV?
Diagnosis, Staging, and Disease progression
- HDV-RNA assays: performances and clinical challenges
- Fibroscan and other non-invasive markers
- Risk for hepatic decompensation
- HCC risk
Current and new antiviral treatments
- PEG-IFNa: still an option?
- Bulevirtide mono and combination therapy
- Bulevirtide in special populations
- Can we stop Bulevirtide? Lessons learned from viral kinetics modelling
- Antibodies against HBsAg to treat HDV infection
- siRNAs against HBsAg to treat HDV infection
New EASL HBV Guidelines: Implications for Hepatitis D
